Other
Egg
Egg is an intervention with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
20%
Ph not_applicable
3
60%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Other(1)
Detailed Status
Completed4
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (25.0%)
N/A3 (75.0%)
Trials by Status
unknown120%
completed480%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Protein Plus: Improving Infant Growth Through Diet and Enteric Health
NCT03683667
completednot_applicable
Protein Source on Plasma Amino Acid Concentrations In Older Adults
NCT04243395
unknownnot_applicable
The Bangladesh Environmental Enteric Dysfunction Study
NCT02812615
completednot_applicable
Protein Source on Plasma Amino Acid Concentrations
NCT03649568
completed
LULUN PROJECT II - Cohort Follow-up Study
NCT03902145
Clinical Trials (5)
Showing 5 of 5 trials
NCT03683667Phase 2
Protein Plus: Improving Infant Growth Through Diet and Enteric Health
NCT04243395Not Applicable
Protein Source on Plasma Amino Acid Concentrations In Older Adults
NCT02812615Not Applicable
The Bangladesh Environmental Enteric Dysfunction Study
NCT03649568Not Applicable
Protein Source on Plasma Amino Acid Concentrations
NCT03902145
LULUN PROJECT II - Cohort Follow-up Study
All 5 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 5